FENC - Fennec Pharmaceuticals Inc.

Over the past 90 days, insiders at Fennec Pharmaceuticals Inc. (FENC) have been net sellers, shedding 112,545 shares worth roughly $1.3M on balance.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Southpoint Capital Advisors LP	2.74M	$29.37M	-
CFO	Robert Andrade	248.6K	$2.66M	-
Dir	Rosty Raykov	124.4K	$1.33M	-
CEO	Jeffrey S. Hackman	70.8K	$758.0K	-
Dir	Chris A Rallis	63.1K	$674.9K	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 2, 2026	Rosty Raykov51	Director	Sale+OE10b5-1	10,079	$8.36	$84,260.44	-8.8%	+20.5%	-
Feb 2, 2026	Rosty Raykov51	Director	Sale+OE10b5-1	10,349	$7.76	$80,308.24	-9.5%	-15.1%	-
Jan 2, 2026	Rosty Raykov51	Director	Sale+OE10b5-1	10,312	$7.60	$78,371.20	-10.5%	-16.4%	-
Dec 24, 2025	Southpoint Capital Advisors LP47	10% Owner	Sell	1,000,000	$7.50	$7,500,000.00	-26.7%	-21.5%	-
Dec 5, 2025	Rosty Raykov51	Director	Sell10b5-1	10,000	$7.54	$75,400.00	-11.4%	+5.0%	-
Nov 18, 2025	Southpoint Capital Advisors LP47	10% Owner	Sell	19,341	$8.79	$170,048.01	-0.5%	-0.8%	-
Nov 17, 2025	Southpoint Capital Advisors LP47	10% Owner	Sell	246,018	$8.27	$2,035,625.21	-6.1%	-0.8%	-
Nov 5, 2025	Rosty Raykov51	Director	Sell10b5-1	10,000	$8.10	$81,000.00	-10.8%	-4.1%	-
Oct 10, 2025	Chris A Rallis60	Director	Sale+OE10b5-1	1,775	$9.24	$16,401.00	-3.0%	-11.6%	+25.0%
Oct 9, 2025	Southpoint Capital Advisors LP47	10% Owner	Sell	67,114	$9.48	$636,228.85	-1.6%	-18.5%	+14.8%